首页> 外文期刊>Analytical chemistry >Single-Cell, Multiplexed Protein Detection of Rare Tumor Cells Based on a Beads-on-Barcode Antibody Microarray
【24h】

Single-Cell, Multiplexed Protein Detection of Rare Tumor Cells Based on a Beads-on-Barcode Antibody Microarray

机译:基于条码条形码抗体微阵列的罕见肿瘤细胞单细胞,多路蛋白质检测。

获取原文
获取原文并翻译 | 示例
           

摘要

Circulating tumor cells (CTCs) shed from tumor sites and represent the molecular characteristics of the tumor. Besides genetic and transcriptional characterization, it is important to profile a panel of proteins with single-cell precision for resolving CTCs' phenotype, organ-of-origin, and drug targets. We describe a new technology that enables profiling multiple protein markers of extraordinarily rare tumor cells at the single cell level. This technology integrates a microchip consisting of 15000 60 pL-sized microwells and a novel beads-on-barcode antibody microarray (BOBarray). The BOBarray allows for multiplexed protein detection by assigning two independent identifiers (bead size and fluorescent color) of the beads to each protein. Four bead sizes (1.75, 3, 4.5, and 6 gm) and three colors (blue, green, and yellow) are utilized to encode up to 12 different proteins. The miniaturized BOBarray can fit an array of 60 pL-sized microwells that isolate single cells for cell lysis and the subsequent detection of protein markers. An enclosed 60 pL-sized microchamber defines a high concentration of proteins released from lysed single cells, leading to single-cell resolution of protein detection. The protein markers assayed in this study include organ specific markers and drug targets that help to characterize the organ-of-origin and drug targets of isolated rare tumor cells from blood samples. This new approach enables handling a very small number of cells and achieves single-cell, multiplexed protein detection without loss of rare but clinically important tumor cells.
机译:循环肿瘤细胞(CTC)从肿瘤部位脱落,代表肿瘤的分子特征。除了遗传和转录特征外,重要的是以单细胞精度分析一组蛋白质,以解决CTC的表型,起源器官和药物靶标。我们描述了一种新技术,该技术能够在单个细胞水平上分析极其罕见的肿瘤细胞的多种蛋白质标记。该技术集成了一个微芯片,该芯片由15000个60 pL大小的微孔和一个新颖的条码微珠抗体微阵列(BOBarray)组成。 BOBarray通过为每种蛋白质分配两个独立的珠子标识符(珠子大小和荧光颜色)来进行多重蛋白检测。四种珠子大小(1.75、3、4.5和6克)和三种颜色(蓝色,绿色和黄色)被用来编码多达12种不同的蛋白质。小型化的BOBarray可以容纳60个pL大小的微孔阵列,这些微孔可分离单个细胞以进行细胞裂解和随后的蛋白质标记物检测。封闭的60 pL大小的微腔室定义了从裂解的单细胞释放的高浓度蛋白质,从而实现了蛋白质检测的单细胞分辨率。在这项研究中测定的蛋白质标记物包括器官特异性标记物和药物靶标,有助于表征血液样本中分离的稀有肿瘤细胞的起源器官和药物靶标。这种新方法能够处理非常少量的细胞,并实现单细胞,多路蛋白质检测,而不会丢失稀有但具有临床意义的肿瘤细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号